|
BRNS Barinthus Biotherapeutics Plc 1828185 |
| Balance Sheet |
|
Current Assets
|
134,654,000 |
|
Assets
|
188,689,000 |
|
Current Liabilities
|
15,072,000 |
|
Liabilities
|
29,228,000 |
|
Equity
|
159,461,000 |
|
Shares Out
|
39,033,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-42,026,000 |
|
Investing Cash Flow
|
-614,000 |
| Market Analysis |
Market Cap
|
49,662,546 |
|
Price
|
1.04 |
|
BVPS
|
4.09 |
|
PB
|
0.25 |
|
EPS
|
-1.65 |
|
PS
|
0.83 |
|
FCF
|
-42,640,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BRNS documents filed with the SEC.
BRNS Filings
Clear
